o(6)-benzylguanine has been researched along with Leukemia L 1210 in 2 studies
O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maze, R | 2 |
| Kurpad, C | 2 |
| Pegg, AE | 1 |
| Erickson, LC | 2 |
| Williams, DA | 2 |
| Pegg, A | 1 |
2 other studies available for o(6)-benzylguanine and Leukemia L 1210
| Article | Year |
|---|---|
Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O6-methylguanine DNA methyltransferase protects hematopoietic cells against O6-benzylguanine sensitization to chloroethylnitrosourea treatment.
Topics: Animals; Antineoplastic Agents; Carcinoma; Ethylnitrosourea; Female; Genetic Vectors; Guanine; Hemat | 1999 |
Protection of hematopoietic cells against combined O6-benzylguanine and chloroethylnitrosourea treatment by mutant forms of O6-methylguanine DNA methyltransferase.
Topics: Animals; Antineoplastic Agents; Carmustine; DNA Repair; Drug Resistance; Gene Expression; Genetic Th | 2000 |